BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20440851)

  • 1. Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies.
    Luo W; Numata K; Morimoto M; Nozaki A; Ueda M; Kondo M; Morita S; Tanaka K
    World J Gastroenterol; 2010 May; 16(17):2109-19. PubMed ID: 20440851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal liver tumors: characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT.
    Luo W; Numata K; Morimoto M; Kondo M; Takebayashi S; Okada M; Morita S; Tanaka K
    Radiology; 2009 Apr; 251(1):287-95. PubMed ID: 19221060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
    Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US.
    Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH
    Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions.
    Youk JH; Kim CS; Lee JM
    J Ultrasound Med; 2003 Sep; 22(9):897-910. PubMed ID: 14510261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US.
    Dill-Macky MJ; Burns PN; Khalili K; Wilson SR
    Radiology; 2002 Jan; 222(1):95-102. PubMed ID: 11756711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US characterization of focal hepatic lesions with intermittent high-acoustic-power mode and contrast material.
    Quaia E; Bertolotto M; Calderan L; Mosconi E; Mucelli RP
    Acad Radiol; 2003 Jul; 10(7):739-50. PubMed ID: 12862283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional contrast-enhanced sonography of vascular patterns of focal liver tumors: pilot study of visualization methods.
    Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Tanaka K
    AJR Am J Roentgenol; 2009 Jan; 192(1):165-73. PubMed ID: 19098197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index.
    Luo W; Numata K; Kondo M; Morimoto M; Sugimori K; Hirasawa K; Nozaki A; Zhou X; Tanaka K
    J Ultrasound Med; 2009 Apr; 28(4):439-48. PubMed ID: 19321671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D analysis is superior to 2D analysis for contrast-enhanced ultrasound in revealing vascularity in focal liver lesions - A retrospective analysis of 83 cases.
    Dong FJ; Xu JF; Du D; Jiao Y; Zhang L; Li M; Liu HY; Xiong Y; Luo H
    Ultrasonics; 2016 Aug; 70():221-6. PubMed ID: 27235776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions.
    Xu J; Wu Y; Dong F
    J Huazhong Univ Sci Technolog Med Sci; 2007 Dec; 27(6):703-5. PubMed ID: 18231748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
    Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E
    BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.
    Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ
    Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.
    Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Zhou X; Tanaka K
    Eur J Radiol; 2009 Dec; 72(3):425-31. PubMed ID: 18930616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal Liver Lesions: Real-time 3-Dimensional Contrast-Enhanced Ultrasonography Compared With 2-Dimensional Contrast-Enhanced Ultrasonography and Magnetic Resonance Imaging.
    Lee JC; Yan K; Lee SK; Yang W; Chen MH
    J Ultrasound Med; 2017 Oct; 36(10):2015-2026. PubMed ID: 28646628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
    J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.